ArticleSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread.
Article in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Safety of furazolidone-containing regimen inBMJ open · 2020Pooled it
- Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments forWorld journal of gastroenterology · 2019Trial
- Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.Clinical and experimental medicine · 2018Trial
- Eradication efficacy of empiric bismuth quadruple therapy containing amoxicillin in the first-line treatment of Helicobacter pylori in Ningxia, China.BMC gastroenterology · 2026Article
- Diagnosis and treatment ofFuture microbiology · 2025Review
- Efficacy and Safety of Modified Bismuth Quadruple Therapy for First-LineMicroorganisms · 2025Review
- Implications of the paradigm shift in management ofTherapeutic advances in gastroenterology · 2023Review
- Short-term outcomes and intermediate-term follow-up ofBMJ open · 2022Observational
- Current guidelines forWorld journal of clinical cases · 2022Review
- Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.Nature reviews. Gastroenterology & hepatology · 2021Review
- Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-ResistantAntibiotics (Basel, Switzerland) · 2021Article
- Susceptibility-guided bismuth quadruple therapies for resistantPrecision clinical medicine · 2020Article
- Effective therapeutic regimens in two South Asian countries with high resistance to majorAntimicrobial resistance and infection control · 2019Article
- Outcomes of furazolidone- and amoxicillin-based quadruple therapy forWorld journal of gastroenterology · 2018Article
- Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.Digestive diseases and sciences · 2017Review
- Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.Cleveland Clinic journal of medicine · 2017Review
- Helicobacter pylori therapy: a paradigm shift.Expert review of anti-infective therapy · 2016Review
- Furazolidone and Helicobacter pylori Treatment.Middle East journal of digestive diseases · 2015Article
- Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori.Medical journal of the Islamic Republic of Iran · 2015Article
- Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.